Work

Dual incretin agonist for paediatric type 2 diabetes: an eagerly awaited opportunity

Year: 2025

Type: article

Source: The Lancet

DOI: 10.1016/s0140-6736(25)01908-7

Authors: Elvira Isganaitis, Lori M Laffel

Institutions: Joslin Diabetes Center, Harvard University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Award: Diabetes Research Center

OpenAlex ID: W4414400573

FWCI:

Cites: 14

Cited by:

Related to: 10